ONE VIAL AT A TIME
Live / Applied — Second extension granted (statement of use) (as of 16 Feb 2026)
What this means for you
Not registered yet, but its 25 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98466137
- Mark type
- Stylized text
- Filed
- 25 Mar 2024
- Published for opposition
- 24 Dec 2024
- Attorney of record
- Michael S. Hargis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, heart failure, heart disease, and hypertension; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for the treatment of cancer, heart failure, heart disease, and hypertension, in the form of oncology injectables and oral solids
Owner
- Areva Pharmaceuticals Inc., Georgetown, IN, US
- Areva Pharmaceuticals Inc., Georgetown, IN, US
Prosecution history
- 28 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2026 — SOU EXTENSION 2 GRANTED
- 16 Feb 2026 — SOU EXTENSION 2 FILED
- 16 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2025 — SOU EXTENSION 1 GRANTED
- 25 Jul 2025 — SOU EXTENSION 1 FILED
- 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 05 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2024 — PUBLISHED FOR OPPOSITION